Mission Hills Financial Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mission Hills Financial Advisory’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.64M	Buy	36,316 +414	+1%	+$51.7K	2.37%	16
2025 Q4	$4.38M	Buy	35,902 +61	+0.2%	+$6.99K	2.31%	16
2025 Q3	$3.59M	Buy	35,841 +157	+0.4%	+$14.1K	1.91%	19
2025 Q2	$2.96M	Sell	35,684 -668	-2%	-$53.3K	1.84%	19
2025 Q1	$2.95M	Buy	36,352 +241	+0.7%	+$21.5K	2.05%	18
2024 Q4	$3.25M	Buy	36,111 +4,531	+14%	+$439K	2.52%	16
2024 Q3	$3.25M	Buy	+31,580	New	+$3.1M	2.77%	15

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Mission Hills Financial Advisory's XBI Position: Q1 2026 in Review

Mission Hills Financial Advisory increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.2% in Q1 2026, buying an estimated $51.7K and bringing the position to 36,316 shares worth $4.64M. The position accounts for 2.37% of the portfolio, ranked #16.

Mission Hills Financial Advisory first reported a position in XBI in Q3 2024 and has held it in 7 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Mission Hills Financial Advisory held 36,316 shares of State Street SPDR S&P Biotech ETF worth $4.64M as of Q1 2026.
Mission Hills Financial Advisory bought 414 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $51.7K.
State Street SPDR S&P Biotech ETF made up 2.37% of Mission Hills Financial Advisory's portfolio in Q1 2026, its #16 holding.
Mission Hills Financial Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 7 quarters since.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Mission Hills Financial Advisory's 13F filing for Q1 2026, filed 4 May 2026.